New Covid-19 Variant ‘IHU’ More Infectious Than Omicron Discovered In France

While governments across the world scramble to grapple with a surge in Omicron cases, a new variant named ‘IHU’ has been reported from France with 12 persons testing positive for the new variant.

A new Covid-19 variants is being reported from France | Image for representation

Even as cases of Omicron, a Covid-19 “variant of concern”  identified first in South Africa multiply quickly around the globe, another new Covid-19 variant is being reported from France which is believed to be much more infectious than Omicron. Scientists have named the new variant “IHU”.

What is IHU?

IHU or B.1.640.2  is reportedly a new Covid-18 variant discovered in France by researchers at the Institute IHU Mederranee Infection. According to reports, researchers have claimed that the new variant has 46 more mutations than Omicron, which had already spread like wildfire around the world. The findings, published in a paper, state, “Fourteen amino acid substitutions, including N501Y and E484K, and 9 deletions are located in the spike protein. This genotype pattern led to creating a new Pangolin lineage named B.1.640.2, which is a phylogenetic sister group to the old B.1.640 lineage renamed B.1.640.1”.

The researchers further wrote, “These data are another example of the unpredictability of the emergence of SARS-CoV-2 variants, and of their introduction in a given geographical area from abroad.”

Read more of this report

(Visited 320 times, 1 visits today)
About Cholo Brooks 16091 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.

Be the first to comment

Leave a Reply

Your email address will not be published.


*